Proposal for a revised Reference Concentration (RfC) for manganese based on recent epidemiological studies

Regulatory Toxicology and Pharmacology

Volumn 55, Issue 3, 2009, Pages 330-339

  Bailey, Lisa A ^a   Goodman, Julie E ^a   Beck, Barbara D ^a  

^a GRADIENT   (United States)

Author keywords

Developmental toxicity; Health based criteria; Manganese; Neurotoxicity; Reference Concentration

Indexed keywords

MANGANESE;

ARTICLE; CONCENTRATION (PARAMETERS); HEALTH SURVEY; HUMAN; NEUROTOXICITY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; PRIORITY JOURNAL; REFERENCE VALUE; UNCERTAINTY;

AIR POLLUTANTS, OCCUPATIONAL; ANIMALS; BENCHMARKING; ENVIRONMENTAL MONITORING; HUMANS; MANGANESE; NEUROTOXICITY SYNDROMES; NO-OBSERVED-ADVERSE-EFFECT LEVEL; OCCUPATIONAL EXPOSURE; REFERENCE VALUES; RISK ASSESSMENT; SPECIES SPECIFICITY; UNITED STATES; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY;

EID: 70350427866     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2009.08.005     Document Type: Article

References (64)

1. Agency for Toxic Substances and Disease Registry (ATSDR), 2008. Toxicological Profile for Manganese (Draft). Available from: , September, 539p (accessed on October 23, 2008).
2. Barnes D.G., and Dourson M.L. Reference dose (RfD): description and use in health risk assessment. Regul. Toxicol. Pharmacol. 8 (1988) 471-486
3. Barnes D.G., Daston G.P., Evans J.S., Jarabek A.M., Kavlock R.J., Kimmel C.A., Park C., and Spitzer H.L. Benchmark dose workshop: criteria for use of a benchmark dose to estimate a reference dose. Regul. Toxicol. Pharmacol. 21 (1995) 296-306
4. Bast-Pettersen R., Ellingsen D.G., Hetland S.M., and Thomassen Y. Neuropsychological function in manganese alloy plant workers. Int. Arch. Occup. Environ. Health 77 4 (2004) 277-287
5. Blond M., and Netterstrom B. Neuromotor function in a cohort of Danish steel workers. Neurotoxicology 28 2 (2007) 336-344
6. Blond M., Netterstrom B., and Laursen P. Cognitive function in a cohort of Danish steel workers. Neurotoxicology 28 2 (2007) 328-335
7. Bouchard M., Mergler D., Baldwin M., Panisset M., and Roels H.A. Neuropsychiatric symptoms and past manganese exposure in a ferro-alloy plant. Neurotoxicology 28 2 (2006) 290-297
8. Bouchard M., Mergler D., Baldwin M., Panisset M., Bowler R., and Roels H.A. Neurobehavioral functioning after cessation of manganese exposure: a follow-up after 14 years. Am. J. Ind. Med. 50 11 (2006) 831-840
9. Brenneman K.A., Wong B.A., Buccellato M.A., Costa E.R., Gross E.A., and Dorman D.C. Direct olfactory transport of inhaled manganese ((54)MnCl(2)) to the rat brain: toxicokinetic investigations in a unilateral nasal occlusion model. Toxicol. Appl. Pharmacol. 169 3 (2000) 238-248
10. California Environmental Protection Agency (CalEPA), 2008. Appendix D. Individual Acute, 8-h, and Chronic Reference Exposure Level Summaries. California, Office of Environmental Health Hazard Assessment (OEHHA). In: Air Toxics Hot Spots Program Technical Support Document for the Derivation of Noncancer Reference Exposure Levels, pp. 1-238.
11. Chia S.E., Foo S.C., Gan S.L., Jeyaratnam J., and Tian C.S. Neurobehavioral functions among workers exposed to manganese ore. Scand. J. Work Environ. Health 19 4 (1993) 264-270
12. Clewell H.J., Lawrence G.A., Calne D.B., and Crump K.S. Determination of an occupational exposure guideline for manganese using the benchmark method. Risk Anal. 23 5 (2003) 1031-1046
13. Conolly R.B. Commentary on "Toxicity Testing in the 21st Century: Implications for Human Health Risk Assessment" by Krewski et al. Risk Anal. 29 4 (2009) 480-481
14. Crump K.S. On summarizing group exposures in risk assessment: is an arithmetic mean or a geometric mean more appropriate?. Risk Anal. 18 3 (1998) 293-297
15. Crump K.S. A new method for determining allowable daily intakes. Fund. Appl. Toxicol. 4 (1984) 854-871
16. Crump K.S., and Rousseau P. Results from eleven years of neurological health surveillance at a manganese oxide and salt producing plant. Neurotoxicology 20 2-3 (1999) 273-286
17. Deschamps F.J., Guillaumot M., and Raux S. Neurological effects in workers exposed to manganese. J. Occup. Environ. Med. 43 2 (2001) 127-132
18. Dorman D.C., Brenneman K.A., McElveen A.M., Lynch S.E., Roberts K.C., and Wong B.A. Olfactory transport: a direct route of delivery of inhaled manganese phosphate to the rat brain. J. Toxicol. Environ. Health A 65 20 (2002) 1493-1511
19. Dorman D.C., McManus B.E., Marshall M.W., James R.A., and Struve M.F. Old age and gender influence the pharmacokinetics of inhaled manganese sulfate and manganese phosphate in rats. Toxicol. Appl. Pharmacol. 197 2 (2004) 113-124
20. Dorman D.C., McElveen A.M., Marshall M.W., Parkinson C.U., James R.A., Struve M.F., and Wong B.A. Tissue manganese concentrations in lactating rats and their offspring following combined in utero and lactation exposure to inhaled manganese sulfate. Toxicol. Sci. 84 1 (2005) 12-21
21. Dorman D.C., McElveen A.M., Marshall M.W., Parkinson C.U., James R.A., Struve M.F., and Wong B.A. Maternal-fetal distribution of manganese in the rat following inhalation exposure to manganese sulfate. Neurotoxicology 26 4 (2005) 625-632
22. Dorman D.C., Struve M.F., Marshall M.W., Parkinson C.U., James R.A., and Wong B.A. Tissue manganese concentrations in young male rhesus monkeys following subchronic manganese sulfate inhalation. Toxicol. Sci. 92 1 (2006) 201-210
23. Dorman D.C., Struve M.F., Clewell H.J., and Andersen M.E. Application of pharmacokinetic data to the risk assessment of inhaled manganese. Neurotoxicology 27 5 (2006) 752-764
24. Elder A., Gelein R., Silva V., Feikert T., Opanashuk L., Carter J., Potter R., Maynard A., Ito Y., Finkelstein J., and Oberdorster G. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ. Health Perspect. 114 8 (2006) 1172-1178
25. ENVIRON International Corp., 2008. Comments of the Manganese Interest Group on Health Canada's Proposed "Human Health Risk Assessment for Inhaled Manganese Draft." Manganese Interest Group. Submitted to Health Canada, Air Health Effects Division, June 17, 105p.
26. Erikson K.M., Dorman D.C., Lash L.H., and Aschner M. Persistent alterations in biomarkers of oxidative stress resulting from combined in utero and neonatal manganese inhalation. Biol. Trace Elem. Res. 104 2 (2005) 151-163
27. Gaylor D., Ryan L., Krewski D., and Zhu Y. Procedures for calculating benchmark doses for health risk assessment. Regul. Toxicol. Pharmacol. 28 (1998) 150-164
28. Gibbs J.P., Crump K.S., Houck D.P., Warren P.A., and Mosley W.S. Focused medical surveillance: a search for subclinical movement disorders in a cohort of U.S. workers exposed to low levels of manganese dust. Neurotoxicology 20 2-3 (1999) 299-313
29. Green, J., 2008. Letter Report re: Supplemental Comments of the Manganese Interest Group on the "Supporting Document Draft" dated June, 2007 to the "Human Health Risk Assessment for Inhaled Manganese Draft" which appeared in the Canada Gazette, Part I on April 19, 2008. Kelley, Drye & Warren, LLP (Washington, DC). Report to Manganese Interest Group. Submitted to Health Canada, September 3, 7p.
30. Greiffenstein M.F., and Lees-Haley P.R. Neuropsychological correlates of manganese exposure: a meta-analysis. J. Clin. Exp. Neuropsychol. 29 2 (2007) 113-126
31. HaMai D., Rinderknecht A.L., Guo-Sharman K., Kleinman M.T., and Bondy S.C. Decreased expression of inflammation-related genes following inhalation exposure to manganese. Neurotoxicology 27 3 (2006) 395-401
32. Health Canada, Water, Air & Climate Change Bureau, 2008. Draft Human Health Risk Assessment for Inhaled Manganese, March, 93p.
33. Henriksson J., and Tjalve H. Manganese taken up into the CNS via the olfactory pathway in rats affects astrocytes. Toxicol. Sci. 55 2 (2000) 392-398
34. Klaassen, C.D. (Ed.), 2001. Casarett and Doull's Toxicology: The Basic Science of Poisons, sixth ed., 1280p.
35. Leavens T.L., Rao D., Andersen M.E., and Dorman D.C. Evaluating transport of manganese from olfactory mucosa to striatum by pharmacokinetic modeling. Toxicol. Sci. 97 2 (2007) 265-278
36. Lees-Haley P.R., Rohling M.L., and Langhinrichsen-Rohling J. A meta-analysis of the neuropsychological effects of occupational exposure to manganese. Clin. Neuropsychol. 20 1 (2006) 90-107
37. Lucchini R., Apostoli P., Perrone C., Placidi D., Albini E., Migliorati P., Mergler D., Sassine M.P., Palmi S., and Alessio L. Long-term exposure to 'low levels' of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology 20 2-3 (1999) 287-297
38. Lucchini R., Selis L., Folli D., Apostoli P., Mutti A., Vanoni O., Iregren A., and Alessio L. Neurobehavioral effects of manganese in workers from a ferroalloy plant after temporary cessation of exposure. Scand. J. Work Environ. Health 21 2 (1995) 143-149
39. Mergler D., Huel G., Bowler R., Iregren A., Belanger S., Baldwin M., Tardif R., Smargiassi A., and Martin L. Nervous system dysfunction among workers with long-term exposure to manganese. Environ. Res. 64 (1994) 151-180
40. Meyer-Baron M., Knapp G., Schaper M., and van Thriel C. Performance alterations associated with occupational exposure to manganese - a meta-analysis. Neurotoxicology 30 4 (2009) 487-496
41. Myers J.E., Thompson M.L., Ramushu S., Young T., Jeebhay M.F., London L., Esswein E., Renton K., Spies A., Boulle A., Naik I., Iregren A., and Rees D.J. The nervous system effects of occupational exposure on workers in a South African manganese smelter. Neurotoxicology 24 6 (2003) 885-894
42. Nong A., Teeguarden J.G., Clewell H.J., Dorman D.C., and Andersen M.E. Pharmacokinetic modeling of manganese in the rat IV: assessing factors that contribute to brain accumulation during inhalation exposure. J. Toxicol. Environ. Health A 71 7 (2008) 413-426
43. Nong A., Taylor M.D., Clewell H.J., Dorman D.C., and Andersen M.E. Manganese tissue dosimetry in rats and monkeys: accounting for dietary and inhaled Mn with physiologically based pharmacokinetic modeling. Toxicol. Sci. 108 1 (2009) 22-34
44. Rindernecht, A., McGregor, J., Rouse-Ho, A., Kleinman, M., 2005. Environmental air pollution and in utero brain damage: Maternal manganese (Mn) inhalation alters brain development and susceptibility to postnatal brain injury. Am. J. Obstet. Gynecol. 193(6 (Suppl.)), S36.
45. Rodriguez-Agudelo Y., Riojas-Rodriguez H., Rios C., Rosas I., Sabido Pedraza E., Miranda J., Siebe C., Texcalac J.L., and Santos-Burgoa C. Motor alterations associated with exposure to manganese in the environment in Mexico. Sci. Total Environ. 368 2-3 (2006) 542-556
46. Roels H., Lauwerys R., Buchet J.P., Genet P., Sarhan M.J., Hanotiau I., de Fays M., Bernard A., and Stanescu D. Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system, and some biological indices. Am. J. Ind. Med. 11 (1987) 307-327
47. Roels H.A., Ghyselen P., Buchet J.P., Ceulemans E., and Lauwerys R.R. Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Br. J. Ind. Med. 49 (1992) 25-34
48. Santamaria A.B. Manganese exposure, essentiality & toxicity. Indian J. Med. Res. 128 4 (2008) 484-500
49. Santos-Burgoa C., Rios C., Mercado L.A., Arechiga-Serrano R., Cano-Valle F., Eden-Wynter R.A., Texcalac-Sangrador J.L., Villa-Barragan J.P., Rodriguez-Agudelo Y., and Montes S. Exposure to manganese: health effects on the general population, a pilot study in central Mexico. Environ. Res. 85 (2001) 90-104
50. Standridge J.S., Bhattacharya A., Succop P., Cox C., and Haynes E. Effect of chronic low level manganese exposure on postural balance: a pilot study of residents in southern Ohio. J. Occup. Environ. Med. 50 (2008) 1421-1429
51. Strawson J., Zhao Q., and Dourson M. Reference dose for perchlorate based on thyroid hormone change in pregnant women as the critical effect. Regul. Toxicol. Pharmacol. 39 1 (2004) 44-65
52. Teeguarden J.G., Dorman D.C., Covington T.R., Clewell H.J., and Andersen M.E. Pharmacokinetic modeling of manganese. I. Dose dependencies of uptake and elimination. J. Toxicol. Environ. Health A 77 18 (2007) 1493-1504
53. Teeguarden J.G., Dorman D.C., Nong A., Covington T.R., Clewell H.J., and Andersen M.E. Pharmacokinetic modeling of manganese. II. Hepatic processing after ingestion and inhalation. J. Toxicol. Environ. Health A 77 18 (2007) 1505-1514
54. Teeguarden J.G., Gearhart J., Clewell H.J., Covington T.R., Nong A., and Andersen M.E. Pharmacokinetic modeling of manganese. III. Physiological approaches accounting for background and tracer kinetics. J. Toxicol. Environ. Health A 70 18 (2007) 1515-1526
55. US EPA, 1990. General Quantitative Risk Assessment Guidelines for Noncancer Health Effects (Draft). Technical Panel for the Development of Risk Assessment Guidelines for Noncancer Health Effects Report to US EPA. Risk Assessment Forum ECAO-CIN-538, November.
56. US EPA, 1993. IRIS Record for Manganese (CASRN 7439-96-5). Available from: , 38p. Page last updated January 10, 2008 (accessed on May 29, 2009).
57. US EPA, 1994. Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. Environmental Criteria and Assessment Office (Research Triangle Park, NC), October. EPA-600/8-90/066F. Available from: (accessed on September 30, 2008).
58. US EPA, 2008. IRIS Record for Manganese (CASRN 7439-96-5). Available from: (accessed in May 2009).
59. US EPA, 2000. Benchmark Dose Technical Guidance Document (External Review Draft). Risk Assessment Forum (Washington, DC), EPA/630/R-00/001, October, 87p.
60. US EPA, 2002. December 2002 Final Report A Review of the Reference Dose and Reference Concentration Processes, EPA/630/P-02/002F.
61. US EPA, 2009. EPA-540-R-070-002 OSWER 9285.7-82 January 2009 Risk Assessment Guidance for Superfund Volume I: Human Health Evaluation Manual (Part F, Supplemental Guidance for Inhalation Risk Assessment), Final.
62. Vitarella D., Wong B.A., Moss O.R., and Dorman D.C. Pharmacokinetics of inhaled manganese phosphate in male Sprague-Dawley rats following subacute (14-day) exposure. Toxicol. Appl. Pharmacol. 163 3 (2000) 279-285
63. World Health Organization (WHO), 2001. Chapter 6.8: Manganese. WHO Regional Publications, European Series No. 91. In: Air Quality Guidelines for Europe, second ed. World Health Organization, Regional Office for Europe. Available from: , 13p (accessed on June 01, 2009)
64. Young T., Myers J.E., and Thompson M.L. The nervous system effects of occupational exposure to manganese - measured as respirable dust - in a South African manganese smelter. Neurotoxicology 26 6 (2005) 993-1000